Molecular Mechanism and Therapeutics in Human Cancer
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 30 November 2025 | Viewed by 65
Special Issue Editor
Interests: G-protein coupled receptors (GPCRs) involvement in tumor biology; the role of protease-activated receptors (PARs) oncogenes in cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The field of molecular oncology is advancing greatly due to evolving bioinformatics tools and sequencing technologies. Information on epigenetic regulation of gene expression and copy number of alterations together provide an insight into the complexity of human cancer.
Immunotherapy has changed the landscape of cancer therapy. The discovery of cancer immune checkpoints has practically reformed the war against cancer and our understanding of the human immune response.
Genomic, transcriptomic, and immunohistochemical analyses of tumor tissues have contributed immensely to early cancer. These analyses also provide a wealth of information regarding the molecular mechanisms of cancer stem cells. Translational means for eradicating cancer stem cells are highly warranted and are the focus of current efforts in oncology.
We look forward to receiving your contributions.
Prof. Dr. Rachel Bar-Shavit
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- oncogenes
- Wnt/b-catenin
- G-protein-coupled receptors (GPCR)
- translational means
- cancer stem cells
- ubiquitination and deubiquitinating in cancer
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
